|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 12 of 15 found articles
| Title: |
Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer |
| Author: |
Lynce, Filipa Williams, James T. Regan, Meredith M. Bunnell, Craig A. Freedman, Rachel A. Tolaney, Sara M. Chen, Wendy Y. Mayer, Erica L. Partridge, Ann H. Winer, Eric P. Overmoyer, Beth |
| Appeared in: |
Cancer, chemotherapy and pharmacology |
| Paging: | Volume 87 () nr. 5 pages 673-679 |
| Year: |
2021-02-14 |
| Contents: | |
| Publisher: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 12 of 15 found articles
| << previous | next >> |